vs

Side-by-side financial comparison of NEOGENOMICS INC (NEO) and PROGRESS SOFTWARE CORP (PRGS). Click either name above to swap in a different company.

PROGRESS SOFTWARE CORP is the larger business by last-quarter revenue ($252.7M vs $186.7M, roughly 1.4× NEOGENOMICS INC). PROGRESS SOFTWARE CORP runs the higher net margin — 10.2% vs -57.9%, a 68.0% gap on every dollar of revenue. On growth, PROGRESS SOFTWARE CORP posted the faster year-over-year revenue change (17.5% vs 11.1%). Over the past eight quarters, PROGRESS SOFTWARE CORP's revenue compounded faster (17.0% CAGR vs 6.5%).

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

Progress Software Corporation develops and sells enterprise software products including application development platforms, data connectivity tools, and digital experience solutions. It serves global enterprise clients across finance, healthcare, manufacturing, retail and other sectors, helping organizations build scalable, high-performance business applications and streamline operational workflows.

NEO vs PRGS — Head-to-Head

Bigger by revenue
PRGS
PRGS
1.4× larger
PRGS
$252.7M
$186.7M
NEO
Growing faster (revenue YoY)
PRGS
PRGS
+6.4% gap
PRGS
17.5%
11.1%
NEO
Higher net margin
PRGS
PRGS
68.0% more per $
PRGS
10.2%
-57.9%
NEO
Faster 2-yr revenue CAGR
PRGS
PRGS
Annualised
PRGS
17.0%
6.5%
NEO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
NEO
NEO
PRGS
PRGS
Revenue
$186.7M
$252.7M
Net Profit
$-108.0M
$25.7M
Gross Margin
43.3%
81.6%
Operating Margin
46.9%
15.2%
Net Margin
-57.9%
10.2%
Revenue YoY
11.1%
17.5%
Net Profit YoY
42.0%
2144.6%
EPS (diluted)
$-0.13
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NEO
NEO
PRGS
PRGS
Q1 26
$186.7M
Q4 25
$190.2M
$252.7M
Q3 25
$187.8M
$249.8M
Q2 25
$181.3M
$237.4M
Q1 25
$168.0M
$238.0M
Q4 24
$172.0M
$215.0M
Q3 24
$167.8M
$178.7M
Q2 24
$164.5M
$175.1M
Net Profit
NEO
NEO
PRGS
PRGS
Q1 26
$-108.0M
Q4 25
$25.7M
Q3 25
$-27.1M
$19.4M
Q2 25
$-45.1M
$17.0M
Q1 25
$-25.9M
$10.9M
Q4 24
$1.1M
Q3 24
$-17.7M
$28.5M
Q2 24
$-18.6M
$16.2M
Gross Margin
NEO
NEO
PRGS
PRGS
Q1 26
43.3%
Q4 25
43.8%
81.6%
Q3 25
42.8%
81.0%
Q2 25
42.6%
80.1%
Q1 25
43.6%
80.6%
Q4 24
44.9%
83.0%
Q3 24
44.6%
83.7%
Q2 24
44.1%
81.7%
Operating Margin
NEO
NEO
PRGS
PRGS
Q1 26
46.9%
Q4 25
-7.1%
15.2%
Q3 25
-14.4%
17.6%
Q2 25
-26.3%
16.3%
Q1 25
-16.6%
13.6%
Q4 24
-10.7%
10.0%
Q3 24
-12.6%
22.6%
Q2 24
-13.3%
15.5%
Net Margin
NEO
NEO
PRGS
PRGS
Q1 26
-57.9%
Q4 25
10.2%
Q3 25
-14.4%
7.8%
Q2 25
-24.9%
7.2%
Q1 25
-15.4%
4.6%
Q4 24
0.5%
Q3 24
-10.5%
15.9%
Q2 24
-11.3%
9.2%
EPS (diluted)
NEO
NEO
PRGS
PRGS
Q1 26
$-0.13
Q4 25
$0.59
Q3 25
$0.44
Q2 25
$0.39
Q1 25
$0.24
Q4 24
$0.01
Q3 24
$0.65
Q2 24
$0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NEO
NEO
PRGS
PRGS
Cash + ST InvestmentsLiquidity on hand
$146.1M
$94.8M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$828.8M
$478.3M
Total Assets
$1.3B
$2.5B
Debt / EquityLower = less leverage
2.93×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NEO
NEO
PRGS
PRGS
Q1 26
$146.1M
Q4 25
$159.6M
$94.8M
Q3 25
$164.1M
$99.0M
Q2 25
$154.7M
$102.0M
Q1 25
$346.2M
$124.2M
Q4 24
$367.0M
$118.1M
Q3 24
$362.0M
$232.7M
Q2 24
$355.1M
$190.4M
Total Debt
NEO
NEO
PRGS
PRGS
Q1 26
Q4 25
$341.9M
$1.4B
Q3 25
$1.4B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$541.1M
$1.5B
Q3 24
Q2 24
Stockholders' Equity
NEO
NEO
PRGS
PRGS
Q1 26
$828.8M
Q4 25
$836.6M
$478.3M
Q3 25
$838.3M
$477.7M
Q2 25
$854.0M
$452.7M
Q1 25
$888.3M
$431.8M
Q4 24
$902.3M
$438.8M
Q3 24
$908.2M
$425.6M
Q2 24
$915.9M
$401.7M
Total Assets
NEO
NEO
PRGS
PRGS
Q1 26
$1.3B
Q4 25
$1.4B
$2.5B
Q3 25
$1.4B
$2.4B
Q2 25
$1.4B
$2.4B
Q1 25
$1.6B
$2.5B
Q4 24
$1.6B
$2.5B
Q3 24
$1.6B
$1.6B
Q2 24
$1.6B
$1.6B
Debt / Equity
NEO
NEO
PRGS
PRGS
Q1 26
Q4 25
0.41×
2.93×
Q3 25
2.97×
Q2 25
3.22×
Q1 25
3.50×
Q4 24
0.60×
3.48×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NEO
NEO
PRGS
PRGS
Operating Cash FlowLast quarter
$-8.1M
$62.8M
Free Cash FlowOCF − Capex
$59.9M
FCF MarginFCF / Revenue
23.7%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
2.44×
TTM Free Cash FlowTrailing 4 quarters
$229.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NEO
NEO
PRGS
PRGS
Q1 26
$-8.1M
Q4 25
$1.3M
$62.8M
Q3 25
$8.9M
$73.4M
Q2 25
$20.3M
$30.0M
Q1 25
$-25.3M
$68.9M
Q4 24
$9.8M
$19.7M
Q3 24
$9.2M
$57.7M
Q2 24
$13.9M
$63.7M
Free Cash Flow
NEO
NEO
PRGS
PRGS
Q1 26
Q4 25
$-6.5M
$59.9M
Q3 25
$570.0K
$72.4M
Q2 25
$14.0M
$29.5M
Q1 25
$-29.8M
$67.7M
Q4 24
$-1.8M
$16.8M
Q3 24
$-1.6M
$56.6M
Q2 24
$814.0K
$62.7M
FCF Margin
NEO
NEO
PRGS
PRGS
Q1 26
Q4 25
-3.4%
23.7%
Q3 25
0.3%
29.0%
Q2 25
7.7%
12.4%
Q1 25
-17.8%
28.4%
Q4 24
-1.0%
7.8%
Q3 24
-0.9%
31.7%
Q2 24
0.5%
35.8%
Capex Intensity
NEO
NEO
PRGS
PRGS
Q1 26
Q4 25
4.1%
1.1%
Q3 25
4.4%
0.4%
Q2 25
3.5%
0.2%
Q1 25
2.7%
0.5%
Q4 24
6.7%
1.3%
Q3 24
6.4%
0.6%
Q2 24
8.0%
0.5%
Cash Conversion
NEO
NEO
PRGS
PRGS
Q1 26
Q4 25
2.44×
Q3 25
3.78×
Q2 25
1.76×
Q1 25
6.30×
Q4 24
17.13×
Q3 24
2.03×
Q2 24
3.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NEO
NEO

Segment breakdown not available.

PRGS
PRGS

Maintenanceand Services$187.5M74%
Share File Acquisition$67.5M27%

Related Comparisons